Liquid pharmaceutical formulations for injection comprising yellow 5 or orange G and uses thereof
US10179172B2 · kind B2 · utility
1Cited by
84References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 2014 |
| Grant date | Jan 15, 2019 |
| Priority date | — |
| Expiry date | Dec 4, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/54
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Concentrated, low-viscosity, low-volume liquid pharmaceutical formulations of proteins have been developed. Such formulations can be rapidly and conveniently administered by subcutaneous or intramuscular injection, rather than by lengthy intravenous infusion. These formulations include low-molecular-weight and/or high-molecular-weight proteins, such as mAbs, and viscosity-lowering water soluble organic dyes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.